2/19/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...

2/16/2024China CDC Becomes First WHO Collaboration Centre on Injury Prevention ...

2/16/2024Ethical Concerns Prompt Largest Mass Retraction of Chinese Genetics Pa...

2/16/2024FDA Criticizes Chinese API Producer for Deceptive Practices and Qualit...

2/15/2024LianBio Completes Strategic Review for Winding Down of Its Operations

2/10/2024Recent Executive Moves

2/10/2024Drug R&D and Product Registration News Digest February 2024 (1)

2/8/2024China Drug Sales Performance of Top Seven MNC Pharma Cos in 2023

2/8/2024China Issues the Action Plan for National Emergency Clinical Trials fo...

2/7/2024CDE Issues the Technical Guidelines for Pharmaceutical Research on Mic...

2/7/2024CDE Issues the Dossier References for Drug R&D and Technical Evaluatio...

2/7/2024CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...

2/7/2024CDE Issues the List of Reference Formulations for GQCE Studies (77th B...

2/7/2024NMPA Restores Import, Sales and Use of GSK's BPH Drug

2/7/2024Review and Outlook of China's Foreign Trade of Medicines and Health Pr...

2/7/2024Review of Chinese Anti-tumor Hospital Drug Sales in 2023: Pharnexcloud

2/7/2024China's Basic Medical Insurance System Reports Revenue of CNY 2.7T in ...

2/7/2024Boao Lecheng Pilot Zone Experiments Expedited Entry into China's Healt...

2/7/2024NHC: China Continues to Improve Access to Public Medical Services (Free)

2/7/2024I-Mab to Divest China Operations and Become a US-Focused Biotech

2/7/2024China Proposes Accelerated Approval for Local Production of Biologics

2/7/2024NMPA Issues the Pilot Reform Work Plan for Optimizing Drug Supplementa...

2/7/2024NHSA Solicits Comments for Draft Incentive Document on Initial Pricing...

2/6/2024China Nearly Doubles Class 1 New Drugs in 2023

2/6/2024 Luye Pharma Collaborates with Myung In Pharm in Advancing Treatment f...

2/6/2024Potential Impact of the US Bill on Wuxi AppTec and Its Western Drugmak...

2/6/2024CPC Expels Former Healthare Reform Official

2/6/2024NMPA and Chinese Customs Announce Addition of Hefei Airport as a Drug ...

2/6/2024CDE Issues the Guidelines for Management and Review of Compliance Info...

2/5/2024Eisai Encouraged by Market Potential of Its Alzheimer's Drug Leqembi i...

Page:7/32 Total number of articles:947: [First][<<] [5] [6] [7] [8] [9] [>>] [End]